BSX
Boston Scientific Corp
$44.77
-0.22 (-0.49%)
At close · Jul 10
Market Cap
$66.54B
Shares
1,486,355,179
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-18 | — | |
| 8-K | 2026-05-18 | — | |
| 8-K | 2026-05-05 | 2026-04-30 | |
| 10-Q | 2026-05-01 | 2026-03-31 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-03-30 | 2026-03-28 | |
| DEF 14A | 2026-03-18 | — | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-02-23 | 2026-02-18 | |
| 10-K | 2026-02-17 | 2025-12-31 | |
| 8-K | 2026-02-05 | 2026-02-02 | |
| 8-K | 2026-02-04 | — | |
| 8-K | 2026-01-15 | — | |
| 8-K | 2026-01-15 | 2026-01-14 | |
| 8-K | 2025-11-19 | 2025-11-18 | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-10-23 | 2025-10-22 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-09-04 | 2025-08-29 | |
| 10-Q | 2025-08-01 | 2025-06-30 | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-05-06 | 2025-05-01 | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-04-23 | 2025-04-18 | |
| 8-K | 2025-04-23 | — | |
| DEF 14A | 2025-03-19 | — | |
| 8-K | 2025-02-26 | 2025-02-21 | |
| 10-K | 2025-02-18 | 2024-12-31 | |
| 8-K | 2025-02-12 | 2025-02-09 | |
| 8-K | 2025-02-05 | — | |
| 8-K | 2025-01-16 | — | |
| 8-K | 2024-11-22 | 2024-11-19 | |
| 8-K | 2024-11-15 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-01 | 2024-09-30 | |
| 8-K | 2024-10-23 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-24 | — | |
| 8-K | 2024-05-10 | 2024-05-08 | |
| 8-K | 2024-05-06 | 2024-05-02 | |
| 10-Q | 2024-05-01 | 2024-03-31 | |
| 8-K | 2024-04-24 | — | |
| 8-K | 2024-04-04 | 2024-04-03 | |
| DEF 14A | 2024-03-20 | — | |
| 8-K | 2024-02-27 | 2024-02-22 | |
| 10-K/A | 2024-02-21 | 2023-12-31 | |
| 10-K | 2024-02-20 | 2023-12-31 |
Showing 1–50 of 138 filings
Key facts
CIK
885725
CUSIP
101137107
13F (30d)
124 filings
80 filers
Visit website
Investor relations